Functional Neuroimagings “Overview”

  • Jyoji Nakagawara


Moyamoya disease is characterized by progressive vascular occlusion of the circle of the Willis accompanied by dilated perforating arteries, which are so-called moyamoya vessels, in the regions of basal ganglia and thalami [1]. These findings was defined by cerebral angiography and also classified into the Suzuki's angiographical stages. More recently, the stage of moyamoya disease using magnetic resonance angiography (MRA) was proposed as a less invasive assessment [2]. However, cerebral angiography and/or MRA cannot evaluate cerebral hemodynamics in patients with moyamoya disease, which should be assessed by functional neuroimagings such as 15 O-positron emission tomography (15 O-PET), single photon emission computed tomography (SPECT), and perfusion magnetic resonance imaging/computed tomography (MRI/CT).


Single Photon Emission Compute Tomography Cerebral Blood Flow Magnetic Resonance Angiography Mean Transit Time Moyamoya Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Suzuki J, Takaku A (1969) Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288–299PubMedCrossRefGoogle Scholar
  2. 2.
    Houkin K, Nakayama N, Kuroda S, et al (2005) Novel magnetic resonance angiography stage grading for moyamoya disease. Cerebrovasc Dis 20:347–354PubMedCrossRefGoogle Scholar
  3. 3.
    Ikezaki K, Matsushima T, Kuwabara Y, et al (1994) Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study. J Neurosurg 81:843–850PubMedCrossRefGoogle Scholar
  4. 4.
    Kuwabara Y, Ichiya Y, Sasaki M, et al (1997) Cerebral hemodynamics and metabolism in moyamoya disease — a positron emission tomography study. Clin Neurol Neurosurg 99 Suppl 2: S74–78PubMedCrossRefGoogle Scholar
  5. 5.
    Morimoto M, Iwama T, Hashimoto N, et al (1999) Efficacy of direct revascularization in adult moyamoya disease: haemodynamic evaluation by positron emission tomography. Acta Neurochir (Wien) 141:377–384CrossRefGoogle Scholar
  6. 6.
    Baron JC, Bousser MG, Rey A, et al (1981) Reversal of focal “misery perfusion syndrome” by extra- intracranial arterial bypass in hemodynamic cerebral ischemia: a case study with 15O positron emission tomography. Stroke 12:454–459PubMedCrossRefGoogle Scholar
  7. 7.
    Samson Y, Baron JC, Bousser MG, et al (1985) Effects of extra-intracranial arterial bypass on cerebral blood flow and oxygen metabolism in humans. Stroke 16:609–616PubMedCrossRefGoogle Scholar
  8. 8.
    Powers WJ, Grubb RL Jr, Raichle ME (1984) Physiological responses to focal cerebral ischemia in humans. Ann Neurol 16:546–552PubMedCrossRefGoogle Scholar
  9. 9.
    Touho H, Karasawa J, Ohnishi H, et al (1996) Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99m Tc-HMPAO SPECT and acetazolamide in childhood moyamoya disease. Stroke 27:282–289PubMedCrossRefGoogle Scholar
  10. 10.
    Saito N, Nakagawara J, Nakamura H, et al (2004) Assessment of cerebral hemodynamics in childhood moyamoya disease using a quantitative and a semiquantitative IMP-SPECT study. Ann Nucl Med 18:323–331PubMedCrossRefGoogle Scholar
  11. 11.
    So Y, Lee HY, Kim SK, et al (2005) Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery. Stroke 36:1485–1489PubMedCrossRefGoogle Scholar
  12. 12.
    Kuroda S, Ishikawa T, Houkin K, et al (2005) Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 36:2148–2153PubMedCrossRefGoogle Scholar
  13. 13.
    Fujimura M, Kaneta T, Mugikura S, et al (2007) Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery—middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol 67:273–282PubMedCrossRefGoogle Scholar
  14. 14.
    Iida H, Akutsu T, Endo K, et al (1996) A multicenter validation of regional cerebral blood flow quantitation using [123 I] iodoamphetamine and single photon emission computed tomography. J Cereb Blood Flow Metab 16:781–793PubMedCrossRefGoogle Scholar
  15. 15.
    Iida H, Itoh H, Nakazawa M, et al (1994) Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. J Nucl Med 35:2019–2030PubMedGoogle Scholar
  16. 16.
    Minoshima S, Frey KA, Koeppe RA, et al (1995) A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36:1238–1248PubMedGoogle Scholar
  17. 17.
    Kim KM, Watabe H, Hayashi T, et al (2006) Quantitative mapping of basal and vasareactive cerebral blood flow using split-dose 123 I-iodoamphetamine and single photon emission computed tomography. Neuroimage 33:1126–1135PubMedCrossRefGoogle Scholar
  18. 18.
    Mizumura S, Nakagawara J, Takahashi M, et al (2004) Three-dimensional display in staging hemodynamic brain ischemia for JET study: objective evaluation using SEE analysis and 3D-SSP display. Ann Nucl Med 18:13–21PubMedCrossRefGoogle Scholar
  19. 19.
    Nakagawara J (2007) Cerebral ischemia and single photon emission computed tomography. Jpn J Neurosurg (Tokyo) 16:753–761Google Scholar
  20. 20.
    JET Study Group (2002) Japanese EC-IC Bypass Trial (JET study): study design and interim analysis. Surg Cereb Stroke (Jpn) 30:97–100CrossRefGoogle Scholar
  21. 21.
    Rosen BR, Belliveau JW, Vevea JM, et al (1990) Perfusion imaging with NMR contrast agents. Magn Reson Med 14:249–265PubMedCrossRefGoogle Scholar
  22. 22.
    Warach S, Gaa J, Siewert B, et al (1995) Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 37:231–241PubMedCrossRefGoogle Scholar
  23. 23.
    Wu O, Koroshetz WJ, Ostergaard L, et al (2001) Predicting tissue outcome in acute human cerebral ischemia using combined diffusion- and perfusion-weighted MR imaging. Stroke 32:933–942PubMedCrossRefGoogle Scholar
  24. 24.
    Kudo K, Sasaki M, Ogasawara K, et al (2009) Difference in tracer delay-induced effect among deconvolution algorithms in CT perfusion analysis: quantitative evaluation with digital phantoms. Radiology 251:241–249PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2010

Authors and Affiliations

  1. 1.Department of NeurosurgeryNakamura Memorial HospitalChuo-kuJapan

Personalised recommendations